Western blotting analyses showed that, in cultures of CLL cells alone, ATO significantly reduced the phosphorylation of Akt, PKC, and Lyn, compared to the values of control cells (Figure 3A). The gene discussed is PRRT2; the disease is B-cell chronic lymphocytic leukemia.